| Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association … WN Kernan, B Ovbiagele, HR Black, DM Bravata, MI Chimowitz, ... Stroke 45 (7), 2160-2236, 2014 | 5578* | 2014 |
| Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association L Mosca, EJ Benjamin, K Berra, JL Bezanson, RJ Dolor, DM Lloyd-Jones, ... Circulation 123 (11), 1243-1262, 2011 | 3075 | 2011 |
| Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice … JJ You, DE Singer, PA Howard, DA Lane, MH Eckman, MC Fang, ... Chest 141 (2), e531S-e575S, 2012 | 1269 | 2012 |
| Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines DE Singer, GW Albers, JE Dalen, MC Fang, AS Go, JL Halperin, GYH Lip, ... Chest 133 (6), 546S-592S, 2008 | 1057 | 2008 |
| A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study MC Fang, AS Go, Y Chang, LH Borowsky, NK Pomernacki, N Udaltsova, ... Journal of the American College of Cardiology 58 (4), 395-401, 2011 | 1030 | 2011 |
| A pharmacogenetic versus a clinical algorithm for warfarin dosing SE Kimmel, B French, SE Kasner, JA Johnson, JL Anderson, BF Gage, ... New England Journal of Medicine 369 (24), 2283-2293, 2013 | 850 | 2013 |
| The net clinical benefit of warfarin anticoagulation in atrial fibrillation DE Singer, Y Chang, MC Fang, LH Borowsky, NK Pomernacki, ... Annals of internal medicine 151 (5), 297-305, 2009 | 829 | 2009 |
| Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation MC Fang, Y Chang, EM Hylek, J Rosand, SM Greenberg, AS Go, ... Annals of Internal Medicine 141 (10), 745-752, 2004 | 702 | 2004 |
| Death and disability from warfarin-associated intracranial and extracranial hemorrhages MC Fang, AS Go, Y Chang, EM Hylek, LE Henault, NG Jensvold, ... The American journal of medicine 120 (8), 700-705, 2007 | 621 | 2007 |
| Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study MC Fang, DE Singer, Y Chang, EM Hylek, LE Henault, NG Jensvold, ... Circulation 112 (12), 1687-1691, 2005 | 603 | 2005 |
| Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study AS Go, MC Fang, N Udaltsova, Y Chang, NK Pomernacki, L Borowsky, ... Circulation 119 (10), 1363-1369, 2009 | 579 | 2009 |
| A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score DE Singer, Y Chang, LH Borowsky, MC Fang, NK Pomernacki, ... Journal of the American Heart Association 2 (3), e000250, 2013 | 440 | 2013 |
| Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation MC Fang, AS Go, Y Chang, L Borowsky, NK Pomernacki, DE Singer, ... Journal of the American College of Cardiology 51 (8), 810-815, 2008 | 406 | 2008 |
| Stable nonviral genetic correction of inherited human skin disease S Ortiz-Urda, B Thyagarajan, DR Keene, Q Lin, M Fang, MP Calos, ... Nature medicine 8 (10), 1166-1170, 2002 | 333 | 2002 |
| Age and the risk of warfarin‐associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study MC Fang, AS Go, EM Hylek, Y Chang, LE Henault, NG Jensvold, ... Journal of the American Geriatrics Society 54 (8), 1231-1236, 2006 | 309 | 2006 |
| National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation MC Fang, RS Stafford, JN Ruskin, DE Singer Archives of internal medicine 164 (1), 55-60, 2004 | 298 | 2004 |
| Warfarin discontinuation after starting warfarin for atrial fibrillation MC Fang, AS Go, Y Chang, LH Borowsky, NK Pomernacki, N Udaltsova, ... Circulation: Cardiovascular Quality and Outcomes 3 (6), 624-631, 2010 | 256 | 2010 |
| Health literacy and anticoagulation-related outcomes among patients taking warfarin MC Fang, EL Machtinger, F Wang, D Schillinger Journal of general internal medicine 21 (8), 841-846, 2006 | 239 | 2006 |
| Assessing bleeding risk in patients taking anticoagulants M Shoeb, MC Fang Journal of thrombosis and thrombolysis 35, 312-319, 2013 | 229 | 2013 |
| Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism PP Kneeland, MC Fang Patient preference and adherence, 51-60, 2010 | 198 | 2010 |
